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Aedes aegypti is the primary vector of pathogens such as Zika, dengue, yellow fever 
and chikungunya viruses, making mosquito control for this species a vital part of 
protecting public health. Pesticides used to control the infestation of adult mosquitoes 
that transmit disease, also known as adulticides, prevent the onset and spread of 
vector-borne disease outbreaks. It is essential to conduct mosquito surveillance and to 
determine the insecticide resistance status for populations before adulticiding. Only the 
most effective insecticides should be used to avoid financial loss and ineffective control 
of mosquitoes. Pyrethroids and organophosphates are the most commonly used 
insecticides for mosquito control. Permethrin (a pyrethroid) accounts for 25% of all 
insecticides used throughout the world, and thus pyrethroid resistant mosquito 
populations are of public health concern. Here, the efficacy of active ingredients (AIs) 
(permethrin [pyrethroid], chlorpyrifos [organophosphate]), formulated products 
(Mosquitomist™ [contains chlorpyrifos], Biomist© [contains permethrin]), and synergists 
(piperonyl butoxide, diethyl maleate, s-s-s-tributyl phosphorotrithioate) were evaluated 
for controlling two populations (pyrethroid resistant and susceptible) of Ae. aegypti in a 
laboratory setting. We show that Mosquitomist™ performed best against the pyrethroid 
 
 
 resistant population with a mortality rate of 100% at the diagnostic time. The addition of 
synergists to AIs did not increase the efficacy against the pyrethroid resistant mosquito 
population. This resistance to synergists may due to the mechanism of action working to 
enable this population of mosquitoes to be pyrethroid resistant. Further research is 
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CHAPTER I – INTRODUCTION  
 Aedes (Ae.) aegypti L. is the primary vector of Zika, dengue, chikungunya, and 
yellow fever viruses, making mosquito control for this species a vital part of protecting 
public health (Centers for Disease Control and Prevention [CDC] 2016). The most 
effective method currently available for reducing vector-borne disease is through 
mosquito control (Sun et al. 2014). Integrated mosquito management programs often 
use insecticides to control adult populations of Ae. aegypti (CDC 2016). However, with 
frequent use by mosquito control programs and other sources (e.g., agricultural, 
homeowner), insecticide resistance may develop, especially for active ingredients (AIs) 
used in adulticides. Hence, routine monitoring of insecticide resistance should be 
included in mosquito control programs (Sun et al. 2014, CDC 2016). Most insecticides 
used in mosquito control include AIs such as pyrethroids (e.g., permethrin, bifenthrin, 
deltamethrin) or organophosphates (e.g., malathion, chlorpyrifos). Pyrethroids, used in 
bed nets and other indoor uses to control pests, comprise 25% of the global insecticide 
market due to their low toxicity in humans and high toxicity in insects (Hemingway et al. 
2004). Organophosphates, while not as widely used as pyrethroids, contain AIs that are 
of human health and environmental concerns (Environmental Protection Agency [EPA] 
2018a).  
 The objectives of the current study on Ae. aegypti are to:  
 1) Determine insecticide resistance status to pyrethroid and organophosphate 
formulated products and their AIs; and  
 2) Evaluate the extent to which synergists impact insecticide resistance to 
pyrethroid and organophosphate AIs.
 
 
CHAPTER II – LITERATURE REVIEW 
Aedes Aegypti 
Ae. aegypti are most commonly found in tropical and subtropical areas of the world and 
prefer to blood feed on humans (Centers for Disease Control and Prevention [CDC] 
2012).  Ae. aegypti is considered the primary vector for dengue, yellow fever, 
chikungunya, and Zika (Smith et al. 2016). Dengue is a risk to an estimated 40% of the 
world’s population and yellow fever is responsible for 30,000 deaths worldwide (Smith et 
al. 2016). It is important to understand the status of mosquito resistance to best treat a 
geographic area. If resistance is present in a class of insecticides, ways to efficiently 
identify resistance and knowledge about alternative treatments is vital to prevent a 
public health emergency. In areas with high occurrences of vector-borne disease, bed 
nets treated with permethrin are a cheap, effective solution to combat the incidence of 
disease, especially malaria (Wilson et al. 2014). A meta-analysis concluded that even a 
30% reduction in mosquitoes mortality due to pyrethroids resistance could result in 245 
additional cases of malaria per 1000 people, with an even larger impact on areas that 
depend on bed nets treated with pyrethroids (Churcher et al. 2016). Because 
pyrethroids are currently the only approved insecticides for use on bed nets, it is 
especially important to understand how to combat pyrethroid resistant populations. 
Understanding a mosquito populations current resistance status allows mosquito control 
programs to be more efficient with their budgets, reduce the amount of pesticides being 




 Globally, mosquito-borne diseases are on the rise due, in part, to increased 
global travel, insecticide resistance, and other factors, leading researchers worldwide to 
develop more effective strategies to control mosquitoes (Liu 2015, Hemingway et al. 
2004, Brogdon & McAllister 1998). In both developing and developed countries, public 
health agencies have implemented mosquito control programs that use adulticides as 
one method for controlling mosquito populations and surveillance-based targeted 
control in the form of either formulated products (FPs) and active ingredients (AIs) (Sun 
et al. 2014). The two most common classes of chemicals used as adulticides are 
organophosphates and pyrethroids (CDC 2016). Organophosphate and pyrethroid 
insecticides target the nervous system of mosquitoes (Hemingway & Ranson 2000). 
With long-term and repeated use of insecticides, mosquitoes may develop insecticide 
resistance. Hence, routine testing for insecticide resistance should be conducted to 
ensure that effective products are being used in mosquito control programs (CDC 
2016). Mosquitoes may be exposed to insecticides from private/government mosquito 
control programs, agricultural, and/or home-owner applications (Richards et al. 2018, 
Brogdon et al. 1998, EPA 2018a, EPA 2018b).  
There are multiple types of insecticide resistance including 1) altered target-site 
resistance, 2) metabolic resistance, 3) behavioral resistance, 4) and penetration 
resistance. Behavioral resistance is the ability for an insect to avoid the insecticide and 
has been reported in organophosphate, pyrethroids, and carbamates (Southern Region 
Integrated Pest Management Center [SRIPMC] 2013). Penetration resistance occurs 
when an insect develops a thickened outer cuticle that slows the rate of insecticide 
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absorption and is often present alongside other types of resistance (SRIPMC 2013). 
Metabolic resistance is defined as genetic change, such as mutations in protein-coding 
genes that increase metabolic detoxification, of an insect in response to the exposure to 
a specific toxicant (CDC 2016, SRIPMC 2013). Altered target-site resistance occurs 
when the target-site for a toxin is modified due to a genetic mutation in protein-coding 
genes that decrease sensitivity of target proteins in an insect to reduce the effects of the 
toxin (SRIPMC 2013). Individual mosquitoes that carry resistance alleles may survive 
exposure to the stressor (e.g. AI), and potentially pass this resistance characteristic to 
their offspring, thereby increasing the proportion of resistant insects in a population (Liu 
2015, SRIPMC 2013).  
 Of the four types of insecticide resistance, the two most common types are: 1) 
target-site resistance: insecticide no longer binds to the target-site, and 2) metabolic 
detoxification enzyme-based resistance where levels of esterases, glutathione s-
transferases (GST), or oxidases are modified to prevent the insecticide from reaching 
the action site (Brogdon & McAllister 1998). Esterases, GST, and oxidases are 
members of multigene families responsible for detoxification of xenobiotics, substances 
foreign to the body such as insecticides, in living organisms (Brogdon & McAllister 
1998). The development of resistance varies by geographical area, mosquito species, 
and other environmental factors to which mosquitoes are exposed. Due to the fact that 
several factors are responsible for mosquito resistance, the timeline for the 
development for mosquito resistance is not well characterized in mosquitoes. 
CDC Bottle Bioassay 
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 The most direct, efficient, and cost-effective method for determining insecticide 
resistance is through the CDC bottle bioassay (Brogdon & McAllister 1998). Bottle 
bioassays allow researchers to determine insecticide resistance in a potential vector 
population. The CDC bottle bioassay uses timed mortality data to provide initial 
evidence of insecticide resistance in a given mosquito population. The timed mortality 
data measures the time it takes for the insecticide to penetrate the mosquito, traverse 
the intervening tissues, move to the action site and act on it. The diagnostic dose (DD) 
and diagnostic time (DT) are determined for the tested insecticide in a susceptible 
mosquito population and this serves as reference points for comparison to tested field 
population. Once a DD and DT is determined, it is important to consistently use these 
parameters to assess potential changes in resistance over time for that population 
(CDC 2013).  
 Using a single AI in a bottle bioassay provides data on insecticide resistance to 
that AI in adult mosquitoes. If resistance is detected in a bottle bioassay, one can test 
for resistance mechanisms using a bottle bioassay with synergists. Synergists act by 
stopping a certain detoxification enzyme, oxidase, esterase, or glutathione s-
transferases, from causing resistance to an insecticide and indicates to researchers 
which resistance mechanism or mechanisms may be causing resistance. When a 
synergist is used on a resistant population, one of three things may occur: 1) resistance 
to the insecticide is abolished which dictates that the mechanism of resistance is related 
to the synergist mechanism of action; 2) resistance to the insecticide is partially 
abolished suggesting that the mechanism for that synergist is related to the resistance 
but it is not the only mechanism occurring in the resistance; or 3) resistance to the 
6 
 
insecticide is unaffected suggesting that the mechanism of the synergist is not related to 
the mechanism of resistance for that insecticide. If resistance in present that cannot be 
attributed to the detoxification enzymes, then the cause is likely to be a target site 
mechanism such as sodium channel mutation or insensitivity to acetylcholinesterase 
(CDC 2013). 
Insecticides 
a. Pyrethroids  
 Pyrethroids are a class of insecticides that are a synthetic formulation of 
pyrethrins, which are derived from chrysanthemum flowers (EPA 2018b). Pyrethroid AIs 
bind to the sodium channels in mosquitoes, thereby altering the gate properties (keeps 
the gate open) (Liu 2015). At the cellular level, pyrethroids cause the cell membrane to 
be persistently depolarized and disrupt nerve function, causing synaptic disturbances, 
paralysis, and eventually death (Dong et al. 2014). The consistent opening of sodium 
channels allows the excessive release of acetylcholine, overstimulating nerve and 
muscle fibers, causing death in invertebrates (Leake 1982). Resistance to pyrethroids 
may occur when genetic mutations modify the sodium channel structure, also known as 
knock down resistance, so that the binding affinity of the insecticide AI to the protein is 
altered, potentially diminishing the effects of the insecticide (Liu 2015). Resistance 
resulting from a reduced sensitivity of sodium cannels is called knockdown resistance 
(Liu 2015).   
 Permethrin has been registered as an insecticide with the EPA since 1967 to be 
used in bed nets, flea products for dogs, treating clothing, outdoor insect sprays, 
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agricultural products, and mosquito repellants. Permethrin is the most commonly used 
mosquito adulticide in the United States and is used in 9-10 million acres out of 32-39 
million acres treated with mosquito adulticide annually. Pyrethroids may be applied as 
ultra-low volume spray (ULV) aerosolized droplets that are suspended in the air to kill 
flying mosquitoes on contact and/or as a barrier spray to keep mosquitoes from entering 
an area for a certain period of time. Formulated pyrethroid products can only be applied 
by trained personnel (i.e., public health pest control license) and public health officials. 
When applied in accordance to label instructions, pyrethroids do not pose unreasonable 
risks to humans. Pyrethroids have a low toxicity in mammals and birds but are toxic to 
fish and bees. Label use requires buffer zones to protect water bodies for uses other 
than mosquito control and specific instructions to reduce risk to pollinators. The two 
major mechanisms of pyrethroid resistance in mosquitoes are increased detoxification 
through cytochrome 450 monooxygenases, an oxidase enzyme which is responsible for 
broad detoxification, and mutations in Vssc, the gene that codes for the sodium channel 
proteins and is responsible for knockdown resistance (Smith et al. 2016). 
b. Organophosphates 
 The target-site for organophosphates is acetylcholinesterase, an enzyme that 
breaks down the neurotransmitter acetylcholine in nerve synapses (Brogdon & 
McAllister 1998, Fukuto 1990, Essandoh et al. 2013). Acetylcholine is involved in the 
transmission of nerve impulses to effector cells in the neuromuscular, cholinergic, and 
synaptic junctions (Fukuto 1990). When a nerve impulse is sent down the 
parasympathetic neuron, the acetylcholine that is stored in the vesicles is released into 
the synaptic or neuromuscular junction (Fukuto 1990). The acetylcholine binds to the 
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acetylcholine receptor on the postsynaptic membrane which then stimulates the nerve 
or muscle fiber (Fukuto 1990). Acetylcholinesterase reduces and regulates the 
concentration of acetylcholine in the junction (Fukuto 1990). Organophosphates inhibit 
acetylcholinesterase, which results in a high concentration of acetylcholine in the 
junction, causing the continuous stimulation of the muscle or nerve fiber and the 
eventual exhaustion and tetany, intermittent muscle spasms, for the invertebrate 
(Fukuto 1990). In the case of resistance to organophosphates, esterases commonly 
contribute to resistance (Hemingway & Ranson 2000). Esterase-based resistance 
occurs when mosquito populations select for individuals producing an elevated amount 
of esterases (Hemingway & Ranson 2000). Esterases bind to insecticide AIs, and 
sequester the AIs, hence rendering them ineffective (Hemingway & Ranson 2000).  
 Chlorpyrifos, an insecticide, acaricide, and miticide, is used in agricultural 
markets since 1965 to control pests on foliage and soil and on crops such as soybeans, 
fruit, broccoli, and corn. In non-agricultural settings, chlorpyrifos can be used to prevent 
termites in non-structural wood products, such as fencing, and to kill mosquitoes and 
ants on golf courses and turf. Chlorpyrifos is also registered for use as a mosquito 
adulticide and for roach/ant bait stations. Chlorpyrifos products are either applied using 
ULV, liquid, granules, water dispersible granules, water soluble packets, or wettable 
powders and can be applied to the ground or through aerial equipment. Applying 
chlorpyrifos requires extra precautions such as wearing chemical resistant gloves, 
coveralls, and respirators while also restricting entry to treated areas for a period 
ranging from 24 h to 5 d. In humans, chlorpyrifos acts as a cholinesterase inhibitor and 
can overstimulate the nervous system, causing nausea, dizziness, confusion, and at 
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high doses, respiratory paralysis and death. Chlorpyrifos has been linked to incidents of 
wildlife mortality related to residential, termite, and golf course applications. The EPA 
has since eliminated chlorpyrifos use in residential settings, restricted its use as a 
termiticide, and reduced its use rate on golf courses. During the 2016 EPA assessment 
of chlorpyrifos, it was indicated that with current labeled use, expected residue of 
chlorpyrifos on food crops exceeded the safety standard put in place by the Federal 
Food, Drug, and Cosmetic Act of 1938. The EPA analysis also found that estimated 
drinking water exposure exceeded safe levels, including those from current registered 
food and non-food uses. Even with the assessment’s findings, in March 2017, the EPA 
denied petitions to revoke pesticide tolerances for chlorpyrifos and cancel chlorpyrifos 
registrations. The EPA is currently reviewing the potential effects of chlorpyrifos on 
endangered species and neurodevelopmental issues in humans (EPA 2018a).  
c. Formulated Products and Active Ingredients 
 The FPs tested in the current analysis are Biomist® and Mosquitomist™. Biomist®, 
a pyrethroid based insecticide, contains the AI permethrin and is distributed by Clarke 
Mosquito Control (Clarke 2015). Biomist® components include 3% permethrin (AI), 15% 
piperonyl butoxide (PBO) (synergist), and no more than 82% petroleum distillate mixture 
(Clarke 2015). Biomist® produces toxic effects in fish, aquatic invertebrates, and aquatic 
plants, hence is not allowed to be applied near water bodies (Clarke 2015). 
Mosquitomist™ is an organophosphate which contains the AI chlorpyrifos and is also 
distributed by Clarke Mosquito Control (Clarke 2017). Mosquitomist™ contains 19.36% 
chlorpyrifos (AI), 8.27-11.02% light aromatic solvent naphtha, 2.76-1.13% 1,2,4 
Trimethylbenzene, 0.028-0.11% xylene, and no more than 65% white mineral oil (Clarke 
10 
 
2017). However, Mosquitomist™ does not contain any synergists (unlike Biomist®). 
Mosquitomist™ has toxic effects on fish, aquatic invertebrates, and aquatic plants so is 
not used near water bodies (Clarke 2017).  
Synergists 
 Some FPs have a combination of synergists and AIs to enhance the 
effectiveness of the AI. Some synergists are enzyme inhibitors for specific detoxification 
enzymes present in insects (CDC 2013). Synergists that inhibit metabolic detoxification 
enzymes are esterases, oxidases, and glutathione s-transferases (CDC 2013). If 
resistance to a FP is observed/suspected in a mosquito population, it is important to 
understand what is causing this resistance (CDC 2013). For instance, synergists used 
in a FP may mask underlying resistance to an AI (CDC 2018). Using synergists in CDC 
bottle bioassays that test AIs may help uncover the mechanism of resistance (e.g. 
detoxification enzyme or other cause of resistance) (CDC 2013). Commonly used 
synergists in CDC bottle bioassays are: 1) S-S-S-tributyl phosphorotrithioate (esterase 
inhibitor), 2) diethyl maleate (glutathione transferase inhibitor), and 3) PBO (oxidase 
inhibitor) (CDC 2013).  
 Using S-S-S-tributyl phosphorotrithioate as a synergist will test for esterase-
based resistance (CDC 2013). If there is suspected resistance to an organophosphate, 
then one should use S-S-S-tributyl phosphorotrithioate to test for detoxification-based 
resistance (Hemingway & Ranson 2000). There is a correlation between decreased 
esterase activity and increased resistance to organophosphates where esterase activity 
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was significantly lower in resistant Ae. aegypti when compared to susceptible Ae. 
aegypti (Mazzarri & Georghiou 1995).  
 The synergist diethyl maleate inhibits glutathione transferase, an enzyme that 
detoxifies a broad range of xenobiotics including insecticides (CDC 2013, Hemingway & 
Ranson 2000). Hence, glutathione transferase may affect both pyrethroid and 
organophosphate susceptibility (Hemingway & Ranson 2000). Numerous studies have 
shown that insects resistant to insecticides may have elevated levels of glutathione 
transferase (Hemingway & Ranson 2000, Sani et al. 2014, Che-Mendoza et al. 2009).  
 Piperonyl butoxide inhibits oxidase activity and reduces pyrethroid resistance in 
multiple mosquito species, including Culex and Aedes genera, as it acts as a P450 
inhibitor (CDC 2013, Smith et al. 2016). P450 monooxygenases are an integral part of 
insects’ adaptation to toxic chemicals and are generally the rate-limiting enzyme 
(Hemingway & Ranson 2000). Monooxygenases are important in the metabolism of 
xenobiotics and are a part of the endogenous metabolism system in insects 
(Hemingway & Ranson 2000). Elevated levels of monooxygenase activity are 
associated with pyrethroid resistance in various mosquito species (Hemingway & 
Ranson 2000). Because a major mechanism for resistance in pyrethroids is the 
increased detoxification of xenobiotics through elevated P450 enzymes, using PBO as a 
synergist will help test whether or not resistance to permethrin is due to an increase in 
P450 monooxygenase enzymes (Smith et al. 2016). A previous study on pyrethroid 
resistance in Ae. aegypti found that genes for P-450 and glutathione S-transferases 
were overexpressed in resistant mosquito populations (McAllister et al. 2012).  
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Previous Studies on Resistance 
 Previous studies have shown pyrethroid resistance in various Ae. aegypti 
populations (Richards et al. 2018, Mazzarri & Georghiou 1995, and Lopez et al. 2014). 
Richards et al. (2018) found that, in an Ae. aegypti population from Dallas, Texas, 54% 
of the mosquitoes died in the appropriate diagnostic time, the time required for 97% of 
mosquitoes to die, for permethrin (indicating resistance) (Richards et al. 2018). Mazzari 
& Georghiou (1995) found moderate resistance to multiple pyrethroids, including 
permethrin, in field populations of Ae. aegypti in Venezuela. Mazzarri & Georghiou 
(1995) show that four of six tested Ae. aegypti field populations that were resistant to 8 
pyrethroid insecticides were also resistant to chlorpyrifos. Bisset et al. (2013) found 
100% susceptibility to chlorpyrifos in Ae. aegypti in a Costa Rica population, Mazzari & 
Georghiou (1995) found moderate resistance to chlorpyrifos in an Ae. aegypti 
populations from Venezuela. Researchers and mosquito control programs should be 
wary of drawing conclusions from past studies to implement in their area as multiple 
factors such as species, geographical location, temporality, and on-going mutations can 
affect the resistance of a mosquito population at any given time (Richards et al. 2018, 
McAllister et al. 2012). Even if there has been previous data finding susceptibility to 




CHAPTER III – MATERIALS AND METHODS 
Mosquito Colonies: Susceptible and Resistant 
 Two populations of Ae. aegypti were used in this study (BEI Resources, 
Manassas, VA): 1) Susceptible colony: insecticide susceptible population (generation F-
48) from Costa Rica (catalog # MRA-726), 2) Resistant colony: pyrethroid resistant 
population (generation F-18) from Puerto Rico (catalog # NR-48830). Both mosquito 
colonies were reared using standard procedures (Richards et al. 2009). Two to three 
mosquito egg strips were placed in plastic pans (24 cm x 36 cm x 5 cm) (BioQuip, 
Rancho Dominguez, CA) containing approximately 700mL of tap water from a faucet 
located in a university lab. The mosquitoes were reared in an incubator at 28ºC with a 
14h:10h (light:dark) cycle and 80% humidity. Larvae were fed a 2:1 mixture of liver 
powder and Brewer’s yeast ad libitum until pupation. Pupae were placed in 500 mL 
plastic cups which were then transferred into metal cages (12in x 12in x 12in) (BioQuip, 
Rancho Dominguez, CA) so that mosquito adults could emerge in containment. Adults 
were provided a 20% sucrose solution ad libitum (Richards et al. 2009).  
Insecticides 
Technical grade permethrin (Chem Service, Inc., Coon Rapids, MN; lot # 7281900) and 
chlorpyrifos (Chem Service, Inc., Coon Rapids, MN; lot # 7515500) were used. 
Synergists are as follows: S-S-S-tributyl phosphorotrithioate (Chem Service, Inc., Coon 
Rapids, MN; lot # 7157700), piperonyl butoxide (Chem Service, Inc., Coon Rapids, MN; 
lot # 7361000), and diethyl maleate (Frontier Scientific, Logan, UT; lot # L270046).  
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Biomist© was obtained through Clarke Mosquito Control (St. Charles, IL) (lot 
#1704183091). Mosquitomist™ was obtained through Clarke Mosquito Control (St. 
Charles, IL) (lot # 1704170002). The next step was to create stock solutions of the AIs, 
FPs, and synergists at the diagnostic dose, the dose required to produce susceptibility 
or enhance the effects of insecticides (CDC 2013). AIs, FPs, and synergists were added 
to acetone to create a concentration recommended by the CDC (Table 1) (CDC 2013). 
Stock solution were kept in a refrigerator, at 4ºC, and in light proof bottles (CDC 2013). 
Stock solutions were taken out of the refrigerator at least an hour before use and gently 
swirled (CDC 2013).  
Bioassays 
 The CDC bottle bioassay procedure for synergist testing was used for this study 
(CDC 2013). Several 12-ounce white paper cardboard food containers (Instawares, 
LLC, Kennesaw, GA) and lids were modified to be resting containers for mosquitoes 
between steps. The tops of the lids were cut out and replaced with mesh screen to allow 
air flow into the cartons when mosquitoes were present. A “x” was cut into the side of 
the carton to allow a space for the aspirator to enter and place the mosquitoes into the 
carton. This “x” was then covered with a cotton ball and taped to close the portal into the 
carton and keep the mosquitoes from escaping. The cardboard cartons were carefully 
labeled by study group. Around 12 hours before the study was conducted, 250mL 
Wheaton® bottles were coated with 1 mL of stock solution or 1 ml of acetone for the 
control following the CDC bottle bioassay procedure (CDC 2013). The bottles were then 
placed on a bottle roller, with the caps removed, at 20 revolutions/min for 2-3 minutes 
until dry. Next, we removed the cap and rolled the bottles until all visible signs of the 
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liquid were gone and the bottles are completely dry (CDC 2013). These bottles were 
stored in a dark drawer overnight before use in the bottle bioassay procedure. Each 
bottle and cap were labeled with the name of the chemical coated in the bottle, what 
step in the bioassay it was to be used, and to which group it belonged.  
 The study had six different study groups: 1) Control (Figure 1), 2) FP (Figure 2), 
3) AI alone (Figure 3), 4) S-S-S-tributyl phosphorotrithioate (DEF) and chlorpyrifos 
(Figure 4), 5) Diethyl maleate (DM) and both permethrin and chlorpyrifos (Figure 5), and 
6) Piperonyl butoxide (PBO) and permethrin (Figure 6). PBO is paired with pyrethroid 
AIs, as they inhibit the oxidase enzymes that break down pyrethroids in insects (Smith 
et al. 2014). DEF is combined with organophosphate AIs, as they inhibit esterase, the 
enzyme that breaks down organophosphates (Hemingway & Ranson 2000). DM can be 
combined with either class of insecticide AIs, as it inhibits glutathione transferase, a 
general detoxifying enzyme (Hemingway & Ranson 2000).  
 Each group experienced three steps with approximately 15 adult female 
mosquitoes per bottle. Step 1) mosquitoes were exposed to clean bottle or synergist-
treated bottles for 60 minutes, 2) mosquitoes were transferred to cardboard cartons and 
held for 30 minutes, 3) mosquitoes were exposed to clean bottle, AI, or FP for 120 
minutes. Each bottle was coated, following the CDC bottle bioassay protocol, with 1 mL 
of the appropriate stock solution the night before the experiment and kept in a cool, dark 
drawer until the experiment was ready to be conducted (CDC 2013).  
 The bioassay procedure was split into two groups. The first bioassay was 
conducted using the resistant group of mosquitoes and the second bioassay was 
conducted using the susceptible group of mosquitoes. The second bioassay was 
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conducted immediately after the first using the same bottles as the first bioassay. Five 
researchers assisted in the bottle bioassay procedure, so each was assigned one of the 
six treatment groups, with one researcher having the control and another group. 
Mosquitoes were aspirated out of the colony cage and put into the step one bottles in 
groups of approximately 15 female mosquitoes per/bottle. Once the step one bottles for 
each group were filled, the timer for that group began. This process was repeated for 
each group. When the timer for the group reached one hour, the mosquitoes were 
aspirated out of the bottles and placed into labeled cardboard cartons for 30 minutes so 
that each bottle of mosquitoes was transferred to separate cartons. The mosquitoes 
were then placed into step three bottles. Step three included an assessment of 
insecticide resistance using the CDC bottle bioassay procedure where the dead and 
alive female mosquitoes are counted at time intervals (15, 30, 35, 40, 45, 60, 75, 90, 
105, 120 min), based on the time sheet provided by the CDC (CDC 2013).  
Data Analyses 
 The mortality rate was calculated by finding the average mortality rate of all 4, step 3 
bottles, at each time interval on the bottle bioassay. According to CDC guidelines, 
resistance or susceptibility at the DT can be judged by the following criteria: 97%-100% 
mortality is susceptible, 90%-96% mortality is possible resistance, and ≤ 90% mortality 
is resistance (CDC 2013). The diagnostic time for each insecticide and 
synergist/insecticide was determined by finding what time interval in which 97% 
mortality or greater was achieved in the insecticide susceptible mosquito colony, 
because this colony was used as the reference group.  
17 
 
 The predetermined DT is the most critical time point as it represents susceptibility 
and resistance in the population (CDC 2013). This average was assessed with a 0 or 1 
code for each time interval’s average mortality rate. The binary outcome was 0-96% 
mortality, resistance/developing resistance, (coded as 0) or 97%-100% mortality, 
susceptibility, (coded as 1). Binary logistic regression applying a significance level of P 
< 0.05 in SPSS (SPSS Inc., Chicago, IL) was used to determine if there were 
differences in susceptibility or resistance, using the mortality rate at the DT determined 
by the susceptible population.  
 This analysis was conducted for two objectives: 1) To compare each bottle group in 
the resistant population to the same bottle group in the susceptible population (Tables 
2-9) and 2) To compare AI only groups in the resistant population to the AI combined 







CHAPTER IV – RESULTS 
Insecticide resistance status to pyrethroid and organophosphate formulated products 
and AIs 
  At the DT, the pyrethroid resistant mosquito colony only showed susceptibility to 
Mosquitomist™ (100%). This population showed resistance to Biomist® (46%), 
permethrin (71%), chlorpyrifos (87%), DM and chlorpyrifos (84%), DEF and chlorpyrifos 
(71%), DM and permethrin (0%), and PBO and permethrin (5%) (Figure 7). Statistically 
significant differences were found between the insecticide susceptible population and 
the pyrethroid resistant population in the Biomist®, DM and permethrin, and PBO and 
permethrin groups (Table 14). For the Biomist® group, there was an odds ratio of 26 
which means Biomist®, in the susceptible mosquito colony, is 26 times more likely to 
result in susceptibility than the pyrethroid resistant population (Table 14). In the 
susceptible colony the synergist DM in combination with permethrin was 36 times more 
likely to result in susceptibility than in the pyrethroid resistant population (Table 14). In 
the susceptible colony the synergist PBO in combination with permethrin was 45 times 
more likely to result in susceptibility than in the insecticide resistant population (Table 
14).  
Synergists impact on insecticide resistance to pyrethroid and organophosphate AIs 
 Neither DM nor PBO, in combination with permethrin, showed a statistically 
significant impact on mean mortality rates compared to permethrin alone (Table 15). 
The mortality rate of permethrin alone was 71% at the DT. In comparison, DM in 
combination with permethrin resulted in a mortality rate of 6% and PBO in combination 
19 
with permethrin resulted in a 4% mortality rate (Figure 8). Neither DM nor DEF, in 
combination with chlorpyrifos, had a statistically significant impact on mortality rates 
compared to chlorpyrifos alone (Table 16). The mortality rate of chlorpyrifos alone was 
87% at the DT. In comparison, DEF in combination with chlorpyrifos had a mortality rate 
of 71% and DM in combination with chlorpyrifos resulted in a 6% mortality rate at the DT 
(Figure 8). 












CHAPTER V – DISCUSSION 
 Susceptibility and resistance to AIs and FPs were analyzed in both insecticide 
resistant and susceptible colonies. We show a statistically significant difference in three 
groups’ mortality rates (Biomist® [p= .009], DM in combination with permethrin [p= .019], 
and PBO in combination with permethrin [p= .004]). PBO/permethrin (46% mortality) 
and DM/permethrin (0% mortality) both resulted in the 2 of the lowest mortality rates at 
the DT in the pyrethroid resistant colony (Figure 7). This finding was expected in the 
pyrethroid resistant population, as permethrin is classified as a pyrethroid. This was also 
found in a studies examining synergists in combination with permethrin in a permethrin 
resistant Culex pipiens quinquefasciatus and an Ae. aegypti population (Priester and 
Georghiou 1978 & Astari and Ahmad 2005). Our results demonstrate that this 
combination of synergists and AIs are the least likely to control a pyrethroid resistant 
population. Here, mosquitoes exposed to Mosquitomist™ showed the only susceptible 
mortality rates (100%) at the DT. The pyrethroid resistant colony showed resistance to 
chlorpyrifos (AI in Mosquitomist™), with a mortality rate of 87% at the DT. This may 
suggest that other compounds in Mosquitomist™ are masking resistance to 
chlorpyrifos. This finding is consistent with reported resistance to chlorpyrifos in 
pyrethroid resistant Ae. aegypti populations from Mexico (Lopez et al. 2014; Flores et al. 
2009). Our findings may be useful for determining which insecticides to use on a known 
pyrethroid resistant population.  
 None of the synergists tested resulted in a statistically significant difference in the 
mortality rate in pyrethroid resistant mosquitoes. Previous findings suggest some types 
of synergists may increase mortality in mosquitoes with metabolic resistance (Dadzie et 
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al. 2017). Hence, some synergists may be ineffective in combating resistance due to 
target site mutations, such as knock-down resistance, the mutation found in pyrethroid 
resistant mosquitoes (Kumar et al. 2002 and Sumarnrote et al. 2017). Mazzari & 
Georghiou (1995) found that synergists DEF and PBO did not affect the mortality of a 
pyrethroid resistant Ae.aegypti population. The same study also found that this lack of 
effect on mortality rates was because the resistance was not caused by metabolic 
enzymes. Our findings that synergists did not increase mortality rates in a pyrethroid 
resistant population, in combination with the findings in previous studies (Mazzari & 
Georghiou 1995 and Sumarnrote et al. 2017), suggests that the pyrethroid resistance 
status of our population is due to a target-site mutation. This is an important deciding 
factor when choosing FPs, which may contain synergists, for adulticiding and may 
cause potential issues as many programs lack the capability to differentiate between 
different types of resistance (e.g., metabolic resistance and target-site resistance).  
 Future studies should compare the difference in mortality rates, when using 
synergists, in pyrethroid resistant mosquitoes with a metabolic resistance against those 
with a target site resistance. In addition, understanding the methods to combat the 
effects of other classes of insecticides on pyrethroid resistant mosquitoes could be 
advantageous to discover the best method to combat a pyrethroid resistant mosquito 
population.  
Strengths and Limitations of this Study 
 Few studies have examined resistance versus susceptible status to insecticides 
in a pyrethroid resistant population and even fewer have investigated the extent to 
which synergists may affect mortality rates in resistant mosquitoes. This study was 
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conducted using lab colonized mosquito populations, but future studies may focus on 
field collected mosquitoes. Lab colonized mosquitoes provide assurance that one type 
of resistance mechanism is present in that population, knock-down resistance, in this 
case. This study examined a single AI and FP from two different insecticide classes. 
Numerous types of organophosphates and pyrethroids that can be studied to determine 
differences in susceptibility and resistance. The current study investigated one synergist 
dose for three different synergists, but future studies may want to expand this work to 











CHAPTER VI – CONCLUSION 
 Insecticide resistance is an increasing concern for mosquito control programs 
globally (Liu 2015). The goal of mosquito control programs is to reduce the population of 
mosquitoes and most importantly, to reduce the risk of vector-borne diseases in a 
geographic area. Because pyrethroids are the most commonly used class of insecticide 
internationally, understanding how to best combat this issue is important when making 
choices on what insecticide to spray to control a mosquito population. It is important to 
understand the status of resistance to best treat an area and if there is a current 
resistance to a class of insecticides, to know how to treat that population and prevent a 
public health emergency. We found that exposure to Mosquitomist™ in the mosquito 
resistant colony resulted in the highest mortality rates but mosquitoes exposed to the AI 
(chlorpyrifos alone) in this product showed resistance. Here, the addition of synergists 
to AIs did not increase mortality rates in the pyrethroid resistant mosquito colony; 
however, factors such as mosquito species, geographic area, insecticides, synergists, 
insecticide/synergist doses and other factors may have affected the outcome. More 
research should be conducted to understand the complex relationships between each 
factor and mortality rates. Results of this research shows that synergists may not be 





TABLE 1: Stock Solution Preparation and Diagnostic Times 






of AI per Bottle 
Diagnostic 
Time 
Permethrin 8 mg 1000 mL 8 µg/mL 60 minutes 
Chlorpyrifos 30 mg 1000 mL 30 µg/mL 35 minutes 
Biomist© 150 mg 1000 mL 8 µg/mL 15 minutes 
Mosquitomist™ 258 mg 1000 mL 30 µg/mL 75 minutes 
S-S-S-tributyl phosphorotrithioate 125 mg 1000 mL 125 µg/mL N/A 
Piperonyl Butoxide 400 mg 1000 mL 400 µg/mL N/A 
Diethyl Maleate 80 mg 1000 mL 80 µg/mL N/A 
 
TABLE 2: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with Mosquitomist™ 
Variables in the Equation 




Step 1a Group(1) -.847 1.345 0.397 1 0.529 0.429 0.031 5.985 
Constant -1.099 0.816 1.810 1 0.178 0.333   
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a. Variable(s) entered on step 1: Group. 
TABLE 3: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with Biomist© 
Variables in the Equation 




Step 1a Group(1) 3.283 1.248 6.918 1 0.009 26.667 2.309 30.8000 
Constant -.981 0.677 2.099 1 0.147 0.375   
a. Variable(s) entered on step 1: Group. 
 
TABLE 4: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with Permethrin 
Variables in the Equation 




Step 1a Group(1) 2.120 1.211 3.065 1 0.080 8.333 0.776 8.9470 
Constant -2.303 1.049 4.820 1 0.028 0.100   






TABLE 5: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with Chlorpyrifos 
Variables in the Equation 




Step 1a Group(1) .421 0.923 0.208 1 0.648 1.524 0.250 9.295 
Constant .560 0.627 0.797 1 0.372 1.750   
a. Variable(s) entered on step 1: Group. 
 
TABLE 6: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with DEF and Chlorpyrifos 
Variables in the Equation 




Step 1a Group(1) -.875 1.366 0.411 1 0.522 0.417 0.029 6.064 
Constant -.916 0.837 1.199 1 0.273 0.400   





TABLE 7: Susceptible Colony Compared to Resistant Colony Mortality Rates with DM 
and Permethrin 
Variables in the Equation 




Step 1a Group(1) 3.584 1.528 5.504 1 0.019 36.000 1.803 71.867 
Constant -1.792 1.080 2.752 1 0.097 0.167   
a. Variable(s) entered on step 1: Group. 
 
TABLE 8: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with DM and Chlorpyrifos 
Variables in the Equation 




Step 1a Group(1) .421 0.923 0.208 1 0.648 1.524 0.250 9.295 
Constant -.981 0.677 2.099 1 0.147 0.375   





TABLE 9: Susceptible Aedes aegypti Colony Compared to Resistant Colony Mortality 
Rates with PBO and Permethrin 
Variables in the Equation 




Step 1a Group(1) 3.807 1.308 8.469 1 0.004 45.000 3.465 58.4339 
Constant -1.504 0.782 3.702 1 0.054 0.222   
a. Variable(s) entered on step 1: Group. 
 
TABLE 10: Chlorpyrifos without Synergist Compared to Chlorpyrifos with DEF in the 
Resistant Aedes aegypti Colony 
Variables in the Equation 




Step 1a Group(1) 0.377 0.872 0.187 1 0.665 1.458 0.264 8.048 
Constant 0.182 0.606 0.091 1 0.763 1.200   





TABLE 11: Chlorpyrifos without Synergist Compared to Chlorpyrifos with DM in the 
Resistant Aedes aegypti Colony 
Variables in the Equation 




Step 1a Group(1) 1.540 0.923 2.788 1 0.095 4.667 0.765 28.466 
Constant -.981 0.677 2.099 1 0.147 0.375   
a. Variable(s) entered on step 1: Group. 
 
TABLE 12: Permethrin without Synergist Compared to Permethrin with DM in the 
Resistant Aedes aegypti Colony 
Variables in the Equation 




Step 1a Group(1) -18.900 12118.63 0.000 1 0.999 0.000 0.000 . 
Constant -2.303 1.049 4.820 1 0.028 0.100   






TABLE 13: Permethrin without Synergist Compared to Permethrin with PBO in the 
Resistant Aedes aegypti Colony 
Variables in the Equation 




Step 1a Group(1) -.799 1.308 0.373 1 0.542 0.450 0.035 5.843 
Constant -1.504 0.782 3.702 1 0.054 0.222   
a. Variable(s) entered on step 1: Group. 
 
TABLE 14: Mortality Rates of Pyrethroid Resistant and Susceptible Aedes aegypti 
Colonies. The synergist acronym for S-S-S-tributyl phosphorotrithioate is DEF, piperonyl 
























0.429 0.53 (0.031-5.98) 
Biomist© 
 
















TABLE 15: Difference in Permethrin Alone and Permethrin/Synergist Mortality Rates in 
Resistant Aedes aegypti Colony 





OR P-value 95% CI 
DM 
 
71 06 0.00 0.99 (0.00-0.00) 
PBO 71 04 0.45 0.54 (0.03-5.84) 











1.52 0.648 (0.250-9.29) 
 
























1.524 0.648 (0.250-9.29) 
PBO and 
Permethrin 




45 0.004 (3.46-58.4) 
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TABLE 16: Difference in Chlorpyrifos Alone and Chlorpyrifos/Synergist Mortality Rates 
in Resistant Colony 






OR P-value 95% CI 
DEF 
 
87 71 1.458 0.66 (0.26-8.04) 
DM 87 06 4.667 0.09 (0.76-28.46) 
 












FIGURE 1: Control Flow Chart 
 
FIGURE 2: Formulated Product without Synergist Trial 






4 Bottles of 
Acetone
2 Hours















FIGURE 3: Active Ingredient without Synergist Trial  
 
FIGURE 4: Synergist Trial S-S-S-tributyl Phosphorotrithioate 
 
8 Bottles of Acetone 
1 Hour
8 Cardboard Cartons 
30 Minutes
4 Bottles of (8 µg) 
Permethrin 
2 Hours










4 Bottles of (30µg) 
Chlorpyrifos
2 Hours






FIGURE 5: Synergist Trial Diethyl Maleate  
 
FIGURE 6: Synergist Trial Piperonyl Butoxide 
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FIGURE 7: Proportion of Mortality at Diagnostic Time in Susceptible and Resistant 
Aedes aegypti Colonies 
 
“*” indicates a statistically significant difference between groups. Diagnostic time for Mosquitomist™ is 75 minutes, Biomist© is 15 
minutes, permethrin is 60 minutes, and chlorpyrifos is 35 minutes. The synergist acronym for S-S-S-tributyl phosphorotrithioate is 


































FIGURE 8: Proportion of Mortality at Diagnostic Time using Synergists in Pyrethroid 
Resistant Aedes aegypti Colonies 
 
Diagnostic time for permethrin is 60 minutes and chlorpyrifos is 35 minutes. The synergist acronyms for S-S-S-tributyl 
phosphorotrithioate is DEF, piperonyl butoxide is PBO, and diethyl maleate is DM. Diagnostic times for synergists and AI were 
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